“LEQEMBI” Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Israel By Investing.com Read more
Eisai, Biogen Alzheimer’s drug Leqembi would cost US Medicare up to $5 billion a year, study finds By Reuters Read more